Posters
(results will display both Free Papers & Poster)
Evaluation of visual rehabilitation and corneal scatter following corneal cross-linking for keratoconus management, employing multiple anterior segment imaging devices
Poster Details
First Author: I.Kokkali GREECE
Co Author(s): A. Kanellopoulos G. Asimellis C. Roussou
Abstract Details
Purpose:
To comparatively evaluate corneal scatter measurements employing Scheimpflug imaging densitometry, double-pass wavefront analysis and stray light level measurements following a combined procedure involving partial excimer laser topography-guided normalization and high-irradiance crosslinking for the management of keratoconus.
Setting:
LaserVision.gr Clinical and Research Eye Institute
Methods:
The following devices were employed: (a) the Pentacam, a Scheimpflug imaging device (Oculus Optikgeräte GmbH, Wetzlar, Germany) offering corneal densitometry data, (b) the HD Analyzer (HD Analyzer, Visiometrics, Terrassa, Spain) offering double-pass wavefront analysis point-spread-function analysis, and (c) the C-Quant (Oculus), offering stray-light physiometric data.
25 eyes subjected to a combined procedure involving partial excimer laser topography-guided normalization and high-irradiance crosslinking for the management of keratoconus (Athens Protocol) were examined pre-operatively and 1 month, 3 months and 6 months postoperatively.
Correlations between slit-lamp evaluated cornea clarity, visual rehabilitation and corneal scatter data from the different device measurements were assessed.
Results:
Visual rehabilitation and scatter appear to correlate with a return to pre-operative baseline at 3 months postoperatively. Positive correlations between the three devices was noted in regard to ocular scatter.
Conclusions:
Corneal scatter may be a clinical investigative tool for the evaluation of cross-linking interventions. Transient effects may be documented and correlated to visual rehabilitation. FINANCIAL DISCLOUSRE: One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented